Charlotte Wagner

Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium

P. Voorhees, D. Sborov, F. Locke, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Refractoriness to last line of therapy: how often is it mandated and reported? A systematic review of randomized myeloma trials.

D. Sborov, A. Godara, G. R. Mohyuddin, 2023, Leukemia & lymphoma.